Support our sponsors:

NZX 50 Index	4611.96	2.40
S&P/ASX 200	5191.20	0.00
Dow Jones Industrials	14839.80	21.00

Twitter

Facebook

RSS

Daily ShareChat: Ryman Healthcare

By Jenny Ruth

Monday 6th June 2011

Text too small?

Ryman Healthcare is positioned to continue to benefit from its favourable business model, positive aging population fundamentals and strong management and operations, says Jason Familton, an analyst at First NZ Capital.

Familton has raised his forecast underlying profit for Ryman to $76.8 million for the year ending March 2012 from $75 million previously and his 2013 forecast to $84.8 million from $77.5 million previously.

Familton says the 2012 forecast implies earnings growth of 6.5%, below the medium-term target of 15%. “The main drivers for our slowing earnings growth in full-year 2012 are a flat housing market, new sales numbers being similarly to full-year 2011 and also resale margins declining slightly once again,” he says.

“Key risks to our forecasts remain changes in the general housing market and our house price assumptions. Other risks include the timing of developments being delayed and also execution risk around future land acquisitions.”

First NZ Capital is forecasting zero nominal house price inflation in the year ending March and then a return of close to long-term forecasts of 4.9% in full-year 2013.

Familton has also raised his valuation of the shares significantly from $2.47 to $3.14, partly reflecting changes in his underlying assumptions and Ryman's intention to step up its rate of development.

Rating: Outperform.

Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.